DIATECH HOLDINGS, INC.
13Patents
1Active
13Granted
31Portfolio score
Filing activity: Sep 10, 1991 → Jul 10, 2012
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5225180A | Technetium-99m labeled somatostatin-derived peptides for imaging | Human Necessities | 71 | Expired |
| US5443815A | Technetium-99m labeled peptides for imaging | Emerging Cross-Sectional Technologies | 69 | Expired |
| US5508020A | Technetium-99M labeled peptides for imaging | Human Necessities | 45 | Expired |
| US5620675A | Radioactive peptides | Human Necessities | 36 | Expired |
| US5552525A | Technetium-99m labeled peptides for imaging inflammation | Human Necessities | 26 | Expired |
| US5561220A | Technetium-99m labeled peptides for imaging inflammation | Emerging Cross-Sectional Technologies | 20 | Expired |
| US5489527A | Translation of m-RNA | Chemistry; Metallurgy | 18 | Expired |
| US5405597A | Technetium-99m labeled somatostatin-derived peptides for imaging | Human Necessities | 16 | Expired |
| US5891665A | Untranslated leader sequences from RNA viruses as enhancers of translation | Chemistry; Metallurgy | 11 | Expired |
| US5932189A | Cyclic peptide somatostatin analogs | Human Necessities | 11 | Expired |
| US5788960A | Technetium-99M labeled polypeptides for imaging | Human Necessities | 1 | Expired |
| US9488654B2 | Methods for predicting response of triple-negative breast cancer to therapy | Physics | 0 | Active |
| US5612193A | Translation of mRNA | Chemistry; Metallurgy | 0 | Expired |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.